Healthcare-focused buyout house ArchiMed has bought into Belgium-based Xpress Biologics to finance a 10x expansion of its production capacity, the firm said.
The post ArchiMed looks to replicate impressive Polyplus success with investment in DNA producer Xpress Biologics first appeared on AltAssets Private Equity News.
